Using Intradermal Rabies Vaccine to Boost Immunity in People with Low Rabies Antibody Levels

Table 1

Summary of the results obtained for each participant.

Participant number	Age	Gender	Year last immunised	Vaccine administered on days	Antibody titre in 2007	Pre-booster titre, 2009	Post-booster titre, 2009	Rise in antibody titre following immunisation
1	38	F	2003	0, 54	0.38	0.13	7.79	7.66
2	66	F	2000	0, 28	0.38	0.29	3.42	3.13
3	32	F	2002	0	0.06	0.07	5.92	5.85
4	67	M	2004	0	0.29	0.07	3.42	3.35
5	71	M	2003	0, 28	0.38	0.22	1.97	1.75
6	45	F	1998	0, 28	0.22	0.13	2.60	2.47
7	36	F	2003	0	0.38	0.29	13.5	13.21
8	30	F	2004	0	0.29	0.22	70.15	69.93
9	39	F	2005	0, 28	0.38	0.38	70.15	69.77
10	34	F	2002	0, 7, 21, 28	0.38	0.13	7.79	7.66
11	20	M	1999	0	0.38	0.17	7.79	7.62
12	28	F	2005	0	0.38	0.10	13.5	13.4

All titre results expressed in IU/mL.